PTGS2 and neoplasm: Through the COX-2/PGE2/EP/VEGF pathway, PGE2 can recruit myeloid derived suppressed cells to impaired Tregs and CD8+ T cell function, which can promote the proliferation of liver cancer cells and tumor blood vessels (19).